Nanomab

EUIPO EUIPO 2022 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark Nanomab was filed as Word mark on 02/14/2022 at the European Union Intellectual Property Office.
It was registered as a trademark on 09/20/2022. The current status of the mark is "Trademark registered".

Trademark Details Last update: September 23, 2022

Trademark form Word mark
File reference 018653121
Application date February 14, 2022
Publication date June 13, 2022
Entry date September 20, 2022
Expiration date February 14, 2032

Trademark owner

606 Gangnam Ace Tower G9, 174-10 Jagok-ro
06373 Seoul
KR

Trademark representatives

Avenida Fotógrafo Francisco Cano 91A 03540 Alicante ES

goods and services

5 biological preparations for medical or veterinary purposes; biochemical preparations for medical or veterinary purposes; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceuticals featuring drug delivery system; preparations for intracellular drug delivery; pharmaceuticals for the treatment of immune system disease; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations for the treatment of cells; chemico-pharmaceutical preparations; protein preparations; biotechnological preparations for medical purposes; reagents for medical use; pharmaceuticals for human purposes; biochemical pharmaceuticals; biological tissue cultures for medical purposes; drug delivery agents; diagnostic reagents for medical use; pharmaceuticals

ID: 11018653121